AMP2026_Logo
AMP EUROPE 2026
TALLINN, ESTONIA
June 15–17, 2026
AMP EUROPE 2026
TALLINN, ESTONIA
June 15–17, 2026

PROGRAM COMING SOON

SUBMIT YOUR ABSTRACT

EXPLORE SPONSORSHIP OPPORTUNITIES

IMPORTANT DATES

Opening abstract submission:

December 10, 2025

Deadline abstract submission:

February 20, 2026

Opening registration:

January 14, 2026

Early bird deadline:

March 25, 2026

REASONS TO ATTEND AMP EUROPE

Networking

Access early results

Stay up-to-date

AMP Europe is the only conference that connects trans-Atlantic and global experts at the scientific and commercial frontiers of molecular pathology across diverse health systems. Through world-class educational sessions and unparalleled industry engagement, it’s a forum for attendees to share best practices, harmonize standards and accelerate translation of breakthrough science into clinical practice.

1. Experience a Global Exchange That Inspires Action
Join a truly international community of molecular professionals from Europe, North America and beyond. Exchange ideas, compare approaches across diverse healthcare systems, and collaborate to tackle shared and emerging challenges in precision medicine.
2. Learn from the Minds Moving the Field Forward
Engage with leading researchers and clinicians whose groundbreaking discoveries are transforming diagnostics and redefining patient outcomes. Gain insights you can immediately translate into your lab’s daily practice.
3. Anticipate What’s Next in Molecular Medicine
Explore the technologies, trends and data-driven innovations that are reshaping the future of laboratory diagnostics. Stay ahead of evolving standards and position your laboratory for the next era of precision health.
4. Expand Your Network and Advance Your Career
Meet global leaders, innovators and decision-makers actively shaping the molecular landscape. Build lasting connections, explore career opportunities across borders, and expand your influence within AMP’s global community..
5. Share Your Science and Elevate Your Voice
Showcase your research, case reports or emerging technologies with a truly engaged audience. Gain international visibility, receive expert feedback and spark collaborations that move your ideas, and the field, forward.

ABOUT THE VENUE

Hilton Tallinn Park

Address:

Fr. R. Kreutzwaldi 23,
10147 Tallinn,
Estonia

Book your room

GET ACCESS TO OUR LATEST NEWS

Stay connected with all of the latest updates by signing up to the mailing list.

By clicking on ‘Subscribe’, you agree to receive the newsletter with information on AMP Europe and to analyze it through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. You can revoke your consent at any time for the future as follows. You will find detailed information in our see our privacy statement.

ORGANIZING COMMITTEE

WELCOME ADDRESS FROM THE ORGANIZING COMMITTEE CHAIR

On behalf of the Organizing Committee, I’m thrilled to invite you to the Association for Molecular Pathology (AMP) 2026 Europe Congress, taking place 15–17 June 2026 in Tallinn, Estonia.

AMP is the leading international organization in molecular diagnostics, and this Congress brings together a global community of molecular professionals to exchange knowledge, forge new collaborations, and explore the latest advancements transforming patient care.

Join us in Tallinn, a dynamic city where history meets innovation, for an exciting program highlighting cutting-edge technologies, impactful research, and practical insights in molecular pathology. Whether you’re a researcher, clinician, or industry partner, this meeting offers unparalleled opportunities to learn, connect, and advance your work.

Stay tuned for updates on the scientific program, abstract submissions, and registration details. We can’t wait to welcome you to Estonia in June 2026!

Chair Laura J. Tafe, MD
Lebanon, New Hampshire, USA
Dartmouth Hitchcock Medical Center

amp-laura-tafe

Chair

Laura J. Tafe, MD
Lebanon, New Hampshire, USA
Dartmouth Hitchcock Medical Center

Mafouz_Rami

Vice-Chair

Rami Mafouz, MD, MPH
Beirut, Lebanon
American University of Beirut Medical Center

amp-reddi-h

Committee - Genetics

Honey Reddi, PhD
Sussex, Wisconsin, USA
Belay Diagnostics

amp-Iorgulescu-j

Committee - HemePath

J. Bryan Iorgulescu, MD
Houston, Texas, USA
University of Texas MD Anderson Cancer Center

amp-bard-j

Committee - Infectious Diseases

Jennifer Bard, PhD
Los Angeles, California, USA
Children Hospital Los Angeles

c-bell

Committee - Informatics

Robert C. Bell, MD
Ann Arbor, Michigan, USA
University of Michigan

amp-yemelyanova-a

Committee - Solid Tumors

Anna Yemelyanova , MD
New York, New York, USA
Weill Cornell Medical College

amp-fernanda-sabato

Committee - Tech Topics

M. Fernanda Sabato
Richmond, Virginia, USA
VCU Health

OPPORTUNITY TO CLAIM CME CREDITS

An application will be made to the UEMS EACCME® for CME accreditation of this event.

GET TO KNOW THE ASSOCIATION FOR MOLECULAR PATHOLOGY

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics.

AMP’s 3,000+ members include individuals from academic and community medical centers, government, and industry:

 including pathologist and doctoral scientist laboratory directors, basic and translational scientists, technologists, and trainees.

MORE ABOUT AMP

Laura J. Tafe

Laura Tafe is a Professor of Pathology and Laboratory Medicine at Dartmouth Hitchcock Medical Center in Lebanon, NH where she is the Director of the Laboratory for Clinical Genomics and Advanced Technology (CGAT). She works as a molecular and anatomic pathologist with expertise in pulmonary and GYN pathology and directs the Dartmouth Cancer Center’s Molecular Tumor Board. Dr. Tafe has most recently served as the AMP Past-President and as a member of the Professional Relations Committee.

Rami Mafouz, MD, MPH

Rami Mahfouz is currently a Tenured Professor and Head of Division of Clinical Pathology in the Department of Pathology and Laboratory Medicine at the American University of Beirut Medical Center and the Director of the Histocompatibility and Molecular Diagnostics Laboratory, Director of the Residency Training Program, and Chairman of the Biomedical Institutional Review Board. He is a member of several international and professional societies including the College of American Pathologists (CAP), the American Society of Histocompatibility and Immunogenetics (ASHI) and the American Association of Molecular Pathologists (AMP) where he is serving as the Chair of the International Affairs Committee.

Honey Reddi

Dr. Reddi currently serves as Chief Laboratory Officer for Belay Diagnostics. Prior to her current position, Dr. Reddi was a Professor and Chief of the Division of Clinical Genomics at the Medical College of Wisconsin. With a background in biotechnology and specialized training in Clinical Molecular Genetics from the Mayo Clinic, where she also led a translational research program on thyroid cancer, Dr. Reddi had been recognized for her outstanding contributions to the field. She received the 2023 Outstanding Graduate Educator award for her contributions as faculty and course director to the MS in Precision Medicine at MCW and the 2018 “Women of Innovation Award” for her leadership in bioscience and technology from the Connecticut Technology Council. Dr. Reddi is passionate about mentoring the next generation of laboratory geneticists.

Julian Bryan Iorgulescu

Dr. Bryan is an assistant professor and director of genomic clinical decision support in the Molecular Diagnostics Laboratory at MD Anderson Cancer Center.

Jennifer Bard

Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM is a Professor of Pathology with Clinical Scholar designation in the Department of Pathology, Keck School of Medicine, University of Southern California. She is the Chief of Clinical Operations and Director of the Clinical Microbiology and Virology Laboratories in the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles.

Robert C. Bell

Dr. Robert Bell, MD is a Clinical Assistant Professor of Pathology and Section Head of Informatics for the Division of Genetics & Genomics. With expertise in hematopathology, molecular genetic pathology, bioinformatics, and clinical informatics, he leads efforts to integrate data science and computational tools into diagnostic medicine. Dr. Bell’s work focuses on advancing genomic data interpretation, informatics infrastructure, and precision diagnostics to improve patient care and translational research.

Anna Yemelyanova

Molecular and Surgical pathologist at Weill Cornell Medical College, New York, New York

M. Fernanda Sabato

I am leading the molecular diagnostics field, specializing in genetics and genomics, oncology, precision medicine, and infectious diseases, particularly in hepatitis and transplantation using state of art technologies such as NGS. In this capacity, I collaborate on the development, validation and implementation of innovative molecular diagnostic tests, ensuring their seamless integration into clinical care. By creating, enhancing, and managing quality control (QC) and quality assurance (QA) programs, alongside driving process improvements and strategies to optimize operational efficiency, I manage and lead a molecular high-complexity CLIA/CAP laboratory in an academic medical center.
Soon!